Payments to Acquire Property, Plant, and Equipment of Edwards Lifesciences Corp from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Edwards Lifesciences Corp annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Edwards Lifesciences Corp Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $56,000,000, a 14% decline year-over-year.
  • Edwards Lifesciences Corp annual Payments to Acquire Property, Plant, and Equipment for 2025 was $260,200,000, a 3.1% increase from 2024.
  • Edwards Lifesciences Corp annual Payments to Acquire Property, Plant, and Equipment for 2024 was $252,400,000, a 0.24% decline from 2023.
  • Edwards Lifesciences Corp annual Payments to Acquire Property, Plant, and Equipment for 2023 was $253,000,000, a 3.4% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Edwards Lifesciences Corp Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $260,200,000 +$7,800,000 +3.1% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $252,400,000 -$600,000 -0.24% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $253,000,000 +$8,400,000 +3.4% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $244,600,000 -$81,200,000 -25% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025 2024 FY
2021 $325,800,000 -$81,200,000 -20% 01 Jan 2021 31 Dec 2021 10-K 12 Feb 2024 2023 FY
2020 $407,000,000 +$152,600,000 +60% 01 Jan 2020 31 Dec 2020 10-K 13 Feb 2023 2022 FY
2019 $254,400,000 +$15,700,000 +6.6% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
2018 $238,700,000 +$70,600,000 +42% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $168,100,000 -$8,000,000 -4.5% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $176,100,000 +$73,400,000 +71% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $102,700,000 +$19,800,000 +24% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $82,900,000 -$26,100,000 -24% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $109,000,000 $0 0% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $109,000,000 +$32,400,000 +42% 01 Jan 2012 31 Dec 2012 10-K 20 Feb 2015 2014 FY
2011 $76,600,000 +$14,800,000 +24% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $61,800,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY

Edwards Lifesciences Corp Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $56,000,000 -$9,300,000 -14% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $65,300,000 +$3,800,000 +6.2% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $61,500,000 -$11,200,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024 2024 Q1
Q1 2022 $72,700,000 -$33,300,000 -31% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q1 2021 $106,000,000 +$23,800,000 +29% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $82,200,000 +$40,000,000 +95% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q1 2019 $42,200,000 -$1,000,000 -2.3% 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020 2020 Q1
Q1 2018 $43,200,000 +$27,300,000 +172% 01 Jan 2018 31 Mar 2018 10-Q 26 Apr 2019 2019 Q1
Q1 2017 $15,900,000 -$11,800,000 -43% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018 2018 Q1
Q1 2016 $27,700,000 +$6,900,000 +33% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017 2017 Q1
Q1 2015 $20,800,000 +$6,500,000 +45% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016 2016 Q1
Q1 2014 $14,300,000 -$22,500,000 -61% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015 2015 Q1
Q1 2013 $36,800,000 +$18,800,000 +104% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q1 2012 $18,000,000 +$4,100,000 +29% 01 Jan 2012 31 Mar 2012 10-Q 06 May 2013 2013 Q1
Q1 2011 $13,900,000 +$5,900,000 +74% 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1
Q1 2010 $8,000,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.